The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

18 Aug 2017 17:24

RNS Number : 4663O
AorTech International PLC
18 August 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Aortech Interational Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Richard Griffiths and controlled undertakings

City and country of registered office (if applicable)

St Helier, Jersey, Channel Islands

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

16 August 2017

6. Date on which issuer notified (DD/MM/YYYY):

18 August 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.13%

0.00%

9.13%

5,557,695

Position of previous notification (if

applicable)

14.62%

0.00%

14.62%

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

 

A: Voting rights attached to shares

 

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

 

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

 

GB0000115302

507,294

0

9.13%

0.00%

 

 

 

SUBTOTAL 8. A

507,294

9.13%

 

 

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

 

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

 

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

Blake Holdings Limited

 

4.18%

 

0.00%

 

4.18%

 

 

ORA Limited

 

3.51%

 

0.00%

 

3.51%

 

 

Cream Capital Limited

 

1.44%

 

0.00%

 

1.44%

 

 

 

Total

9.13%

 

0.00%

 

9.13%

 

 

 

10. In case of proxy voting, please identify:

 

Name of the proxy holder

N/A

 

The number and % of voting rights held

N/A

 

The date until which the voting rights will be held

N/A

 

 

11. Additional informationxvi

 

 

 

Place of completion

St Helier, Jersey, Channel Islands

Date of completion

18 August 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGGUUPRUPMGQR
Date   Source Headline
17th Feb 20115:06 pmRNSHolding(s) in Company
17th Jan 20117:00 amRNSAorTech Enters Orthopaedic Market
20th Dec 20107:00 amRNSAorTech Announces Interim Results
13th Dec 20107:00 amRNSAortech Announces Human Use of Header Technology
27th Sep 20103:00 pmRNSResult of AGM
9th Sep 20104:49 pmRNSDirector/PDMR Shareholding
24th Aug 20107:00 amRNSAnnual Report and Accounts
2nd Aug 20107:00 amRNSAorTech Announces Year End Preliminary Results
28th Jul 20108:56 amRNSHolding(s) in Company
24th May 20107:00 amRNSAorTech Signs Licensing Agreement
19th May 20107:00 amRNSDirector/PDMR Shareholding
27th Apr 20108:00 amRNSHolding(s) in Company
12th Mar 20104:50 pmRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSAorTech Announces Interim Results
24th Nov 20097:00 amRNSAorTech Receives Record Polymer Order
29th Sep 20097:00 amRNSAnnual Reports and Accounts Posted to Shareholders
21st Sep 20095:06 pmRNSHolding(s) in Company
16th Sep 20095:19 pmRNSResult of AGM
16th Sep 20097:00 amRNSAorTech Signs Licensing Agreement with SynCardia
16th Sep 20097:00 amRNSAorTech AGM Statement
27th Jul 20097:00 amRNSAorTech Issued US Patent for Polymer Heart Valve
22nd Jul 20097:00 amRNSAorTech Announces Final Results
9th Jul 20095:57 pmRNSHolding in Company - correction
19th Jun 200910:53 amRNSHolding(s) in Company
17th Jun 200912:07 pmRNSHolding(s) in Company
15th Jun 20095:13 pmRNSHolding(s) in Company
15th Jun 20095:11 pmRNSHolding(s) in Company
10th Jun 20097:00 amRNSAorTech Signs Licensing Agreement
5th Jun 200912:38 pmRNSHolding(s) in Company
18th May 20097:00 amRNSAorTech Signs Licensing Agreement
5th May 20099:18 amRNSHolding(s) in Company
6th Apr 20097:00 amRNSAorTech International Director/PDMR Shareholding
29th Jan 20097:00 amRNSAorTech Expands Agreement with St. Jude Medical
17th Dec 20087:00 amRNSAorTech Announces Half Yearly Results
8th Dec 20087:00 amRNSAorTech Signs New Licensing Agreement
25th Nov 20087:00 amRNSFDA Approval Granted to Key AorTech Customer
30th Sep 200810:47 amRNSHolding(s) in Company
19th Sep 200810:24 amRNSAnnual Report and Accounts
12th Sep 200812:53 pmRNSHolding(s) in Company
8th Sep 20082:22 pmRNSHolding(s) in Company
27th Aug 20082:50 pmRNSResult of AGM
27th Aug 20087:00 amRNSAGM Statement
26th Aug 200810:00 amRNSAgreement
21st Aug 20087:00 amRNSAorTech Issued Patent for Bio
6th Aug 20087:00 amRNSHolding(s) in Company
4th Aug 20087:00 amRNSAorTech Issued Patent for Pol
28th Jul 20087:00 amRNSSuccess in Animal Trials
23rd Jul 20087:00 amRNS1st Human Use of Cardiac Cann
17th Jun 20087:00 amRNSFinal Results
17th Apr 20085:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.